Earnings per share for the last twelve months: Phibro Animal Health Corp (PAHC)

Phibro Animal Health faces pricing pressure and stringent oversight of antibiotics. However, its status as a global leader in veterinary medicine and a vast patent portfolio ensure global food security. The company maintains premium pricing on vaccines, although basic supplements are constrained by competition. The 12-month net income per share trend helps avoid overvalued assets, and the 2.53 indicator reflects current dynamics.

Phibro Animal Health's complex international logistics and sales diversification support high margins, which directly impact the bottom-line net income. This metric measures the share of actual income per share annually, allowing investors to identify any imbalance between real profits and revenue on the annual net income per share chart.